Wellington Management Group
TVTX icon

Wellington Management Group’s Travere Therapeutics TVTX Stock Holding History

Wellington Management Group’s Portfolio TVTX Stock Details TVTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$30.4M Buy
1,022,272
+223,288
+28% +$6.67M 0.01% 878
2025
Q4 		$30.5M Sell
798,984
-402,485
-33% -$13.1M 0.01% 883
2025
Q3 		$28.7M Buy
1,201,469
+1,166,460
+3,332% +$21.9M 0.01% 896
2025
Q2 		$518K Buy
35,009
+1,839
+6% +$30.5K ﹤0.01% 1817
2025
Q1 		$594K Sell
33,170
-323
-1% -$6.55K ﹤0.01% 1796
2024
Q4 		$583K Buy
+33,493
New +$592K ﹤0.01% 1810
2024
Q3 		– Sell
-72,658
Closed -$597K – 2027
2024
Q2 		$597K Buy
72,658
+17,088
+31% +$115K ﹤0.01% 1762
2024
Q1 		$428K Sell
55,570
-86,424
-61% -$729K ﹤0.01% 1823
2023
Q4 		$1.28M Buy
+141,994
New +$1.03M ﹤0.01% 1575
2018
Q4 		– Sell
-33,902
Closed -$974K – 2204
2018
Q3 		$974K Buy
33,902
+1,501
+5% +$42.9K ﹤0.01% 1883
2018
Q2 		$883K Buy
32,401
+22,658
+233% +$603K ﹤0.01% 1917
2018
Q1 		$218K Hold
9,743
– – ﹤0.01% 2150
2017
Q4 		$205K Buy
+9,743
New +$223K ﹤0.01% 2178

Other funds holding TVTX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wellington Management Group's TVTX Position: Q1 2026 in Review

Wellington Management Group increased its Travere Therapeutics (TVTX) stake by 28% in Q1 2026, buying an estimated $6.67M and bringing the position to 1,022,272 shares worth $30.4M. The position accounts for 0.01% of the portfolio, ranked #878.

Wellington Management Group first reported a position in TVTX in Q4 2017 and has held it in 13 quarters since. The position peaked at $30.5M in Q4 2025. 260 funds tracked by Wall St. Rank hold TVTX as of Q1 2026.

  • Wellington Management Group held 1,022,272 shares of Travere Therapeutics worth $30.4M as of Q1 2026.
  • Wellington Management Group bought 223,288 Travere Therapeutics shares in Q1 2026, an estimated $6.67M.
  • Travere Therapeutics made up 0.01% of Wellington Management Group's portfolio in Q1 2026, its #878 holding.
  • Wellington Management Group first reported a position in Travere Therapeutics in Q4 2017 and has held it in 13 quarters since.
  • Wellington Management Group's Travere Therapeutics position peaked at $30.5M in Q4 2025.
  • 260 funds tracked by Wall St. Rank held Travere Therapeutics as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.